Takafumi Iesaki Selected Research

Takafumi Iesaki Research Topics

3	Hypoxia (Hypoxemia) 02/2022 - 08/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 06/2006
2	Inflammation (Inflammations) 01/2011 - 08/2010
1	Magnesium Deficiency (Deficiency, Magnesium) 02/2022
1	Aortic Dissection 12/2021
1	Ischemia 07/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2011
1	Sudden Death 04/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011
1	Thrombosis (Thrombus) 08/2010
1	Hypertension (High Blood Pressure) 08/2010
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 11/2008
1	Pulmonary Arterial Hypertension 07/2007
1	Connective Tissue Diseases (Connective Tissue Disease) 07/2007
1	Hyperglycemia 06/2006
1	Type 2 Diabetes Mellitus (MODY) 06/2006

2	MagnesiumIBA 02/2022 - 04/2011
1	Mitochondrial Permeability Transition PoreIBA 02/2022
1	perlecanIBA 12/2021
1	5-hydroxydecanoic acidIBA 07/2012
1	mitochondrial K(ATP) channelIBA 07/2012
1	paxillineIBA 07/2012
1	Krebs-Ringer solutionIBA 04/2011
1	Aspartic Acid (Aspartate)FDA Link 04/2011
1	TransferasesIBA 04/2011
1	Sirolimus (Rapamycin)FDA Link 01/2011
1	candesartanIBA 01/2011
1	Angiotensin Receptor AntagonistsIBA 08/2010
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2010
1	human ABCD1 proteinIBA 11/2008
1	Uric Acid (Urate)IBA 07/2007
1	Glucose (Dextrose)FDA LinkGeneric 06/2006
1	Triglycerides (Triacylglycerol)IBA 06/2006
1	Nonesterified Fatty Acids (NEFA)IBA 06/2006
1	Acarbose FDA LinkGeneric 06/2006
1	CholesterolIBA 06/2006
1	Insulin (Novolin)FDA Link 06/2006
1	Soluble Guanylyl CyclaseIBA 08/2003
1	Penicillamine (Cuprimine)FDA Link 08/2003
1	Serotonin (5 Hydroxytryptamine)IBA 08/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2003